Editas Medicine to Host Conference Call Discussing Second Quarter 2020 Results and Corporate Update

Rhea-AI Summary

Editas Medicine, a leader in genome editing, will host a conference call on August 6, 2020, at 5:00 p.m. ET to discuss its corporate updates and Q2 2020 results. Participants can join the call by dialing 844-348-3801 (domestic) or 213-358-0955 (international) and using passcode 9185596. A live webcast will also be available on their website. Editas focuses on leveraging CRISPR technology to develop transformative genomic treatments for serious diseases worldwide.

CAMBRIDGE, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, August 6, 2020, at 5:00 p.m. ET to discuss a corporate update and results for the second quarter of 2020.

To access the call, please dial 844-348-3801 (domestic) or 213-358-0955 (international) and provide the passcode 9185596. A live webcast of the presentation will be available on the Investors & Media section of the Editas Medicine website.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Investors
Mark Mullikin
(617) 401-9083
mark.mullikin@editasmed.com

Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

FAQ

When is the Editas Medicine conference call for Q2 2020 results?

Editas Medicine will host the conference call on August 6, 2020, at 5:00 p.m. ET.

How can I access the Editas Medicine conference call?

To access the conference call, dial 844-348-3801 (domestic) or 213-358-0955 (international) and provide the passcode 9185596.

Where can I find the webcast for Editas Medicine's conference call?

A live webcast of the presentation can be found in the Investors & Media section of the Editas Medicine website.

What is the focus of Editas Medicine's work?

Editas Medicine specializes in genome editing using CRISPR technology to develop precision genomic medicines for serious diseases.

What technology does Editas Medicine utilize for genome editing?

Editas Medicine utilizes CRISPR/Cas9 and CRISPR/Cas12a (Cpf1) technologies for genome editing.